OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Empagliflozin: a potential anticancer drug
Wenwen Wu, Yanyan Wang, Jun Xie, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Wenwen Wu, Yanyan Wang, Jun Xie, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Sodium-glucose cotransporter 2 inhibitors and cancer: a systematic review and meta-analysis
Bo Xu, Bo-Kyeong Kang, Shuangjian Li, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 10, pp. 2421-2436
Closed Access | Times Cited: 13
Bo Xu, Bo-Kyeong Kang, Shuangjian Li, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 10, pp. 2421-2436
Closed Access | Times Cited: 13
Exploring the anti-cancer potential of SGLT2 inhibitors in breast cancer treatment in pre-clinical and clinical studies
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176803-176803
Closed Access | Times Cited: 3
Yasaman Naeimzadeh, Amir Tajbakhsh, Mahnaz Nemati, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176803-176803
Closed Access | Times Cited: 3
Risks and Benefits of SGLT-2 Inhibitors for Type 1 Diabetes Patients Using Automated Insulin Delivery Systems—A Literature Review
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
Viviana Elian, Violeta Popovici, Oana Karampelas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 1972-1972
Open Access | Times Cited: 3
Atrial fibrillation in cancer, anticancer therapies, and underlying mechanisms
Adnan Shaaban, Shane S. Scott, Ashley Greenlee, et al.
Journal of Molecular and Cellular Cardiology (2024) Vol. 194, pp. 118-132
Open Access | Times Cited: 3
Adnan Shaaban, Shane S. Scott, Ashley Greenlee, et al.
Journal of Molecular and Cellular Cardiology (2024) Vol. 194, pp. 118-132
Open Access | Times Cited: 3
Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice
Blythe D. Shepard, Jennifer Chau, Ryan Kurtz, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 4, pp. C1272-C1290
Closed Access | Times Cited: 2
Blythe D. Shepard, Jennifer Chau, Ryan Kurtz, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 4, pp. C1272-C1290
Closed Access | Times Cited: 2
Efficacy of SGLT2 inhibitors for anthracycline-induced cardiotoxicity: a meta-analysis in cancer patients
S K Mohsin, Misha Hasan, Zubaid Moazzam Sheikh, et al.
Future Cardiology (2024) Vol. 20, Iss. 7-8, pp. 395-407
Closed Access | Times Cited: 1
S K Mohsin, Misha Hasan, Zubaid Moazzam Sheikh, et al.
Future Cardiology (2024) Vol. 20, Iss. 7-8, pp. 395-407
Closed Access | Times Cited: 1
Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?
Carlos A Gongora, Lili Zhang, Juan Lopez Mattei, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Carlos A Gongora, Lili Zhang, Juan Lopez Mattei, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Comparison of Empagliflozin with other SGLT-2i and the Pharmacological Effects of Empagliflozin
Feiyang Qin
Highlights in Science Engineering and Technology (2024) Vol. 91, pp. 66-72
Open Access
Feiyang Qin
Highlights in Science Engineering and Technology (2024) Vol. 91, pp. 66-72
Open Access
Neuroprotective effect of empagliflozin against doxorubicin-induced chemobrain in rats: interplay between SIRT-1/MuRF-1/PARP-1/NLRP3 signaling pathways and enhanced expression of miRNA-34a and LncRNA HOTAIR
Merihane M. Nasr, Sara A. Wahdan, Reem N. El‐Naga, et al.
NeuroToxicology (2024)
Closed Access
Merihane M. Nasr, Sara A. Wahdan, Reem N. El‐Naga, et al.
NeuroToxicology (2024)
Closed Access
